Capricor Therapeutics, Inc.
OrganizationHeard in 1 episode across 1 show since Jul 2026
Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapies. Its lead candidate, deramiocel (CAP-1002), is an allogeneic cardiosphere-derived cell therapy primarily being developed for the treatment of Duchenne muscular dystrophy.
Episodes
1
across 1 show
First heard
Jul 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 1 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
Episodes
1 episode featuring Capricor Therapeutics, Inc., newest first
